Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 179   

Articles published

BMY 56.64 -0.69 (-1.20%)
price chart
Bristol-Myers Squibb reports data from phase 1/2 trial for cancers associated ...
Bristol-Myers Squibb Co. BMY, -1.20% reported results from a phase 1/2 clinical trial looking at the company's blockbuster cancer drug Opdivo in patients with human papillomavirus (HPV)-associated cancers premarket Friday.
Bristol-Myers Squibb Breaks Above 200-Day Moving Average - Bullish for BMY  Nasdaq
Array BioPharma And Bristol-Myers Squibb Announce Strategic Collaboration  Pharmaceutical Online (press release)
Bristol-Myers Squibb to Sell Manufacturing Facility in Swords, Ireland to SK ...
NEW YORK & DAEJEON, South Korea--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and SK Biotek Co., Ltd. today announced the companies have signed a definitive purchase agreement to sell Bristol-Myers Squibb's small molecule ...
Bristol-Myers Squibb to sell Swords manufacturing facility  Irish Times
Few Things investors Didn't Know About: Bristol-Myers Squibb Company ...  StockNewsJournal
Bristol-Myers Squibb Is Poised for a Breakout
Bristol-Myers Squibb Co. (BMY) has been held in check by a very heavy 200 day moving average for nearly all of 2017. The stock managed to close above this key level on Monday for the first time since early August 2016.
Estimating the intrinsic value of Bristol-Myers Squibb Company (BMY)  Simply Wall St
Bristol-Myers Squibb Company (BMY) Is Now On The Radar Because Of Its ...  NY Stock News
Bristol-Myers Squibb a Top Socially Responsible Dividend Stock With 2.8% Yield ...
Bristol-Myers Squibb Co. (Symbol: BMY) has been named a Top Socially Responsible Dividend Stock by Dividend Channel , signifying a stock with above-average ''DividendRank'' statistics including a strong 2.8% yield, as well as being recognized by ...
Analyzing Bristol-Myers Squibb's Valuation on June 20  Market Realist
Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer  Business Wire (press release)
Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space
In spite of the share price falling more than 30% since mid-2016 after disappointing results for Opdivo in lung cancer in the Checkmate-026 study, I don't think Bristol-Myers Squibb (NYSE:BMY) offers a compelling risk/reward with the stock trading at ...
Bristol-Myers Squibb (BMY) to Present Research on RA Patients With Highly ...
Bristol-Myers Squibb Co (BMY) Put-Call Ratio Skews Positive (blog)
Companies Get New Suit Limits as Supreme Court Backs Bristol-Myers
The U.S. Supreme Court gave companies a new tool to defeat some legal claims, siding with Bristol-Myers Squibb Co. in a bid to limit a consumer lawsuit in California over its Plavix blood thinner.
Supreme Court Decides Bristol-Myers Squibb Co. v. Superior Court, No.16-466.  JD Supra (press release)
Breaking News − Bristol-Myers Squibb Slams The Door On Litigation Tourism  Lexology (registration)
Bristol-Myers Fails To Stem The Losses
... how Asco went for Bristol-Myers Squibb (NYSE:BMY) this year - in the minds of investors at least. Despite laying out plans for its next wave of immuno-oncology assets at an event over the weekend, the company failed to quash concerns that it is ...
Bristol-Myers Squibb to Take Part in Goldman Sachs 38  Business Wire (press release)
Lookout for Price Target? Bristol-Myers Squibb Company (BMY), Walgreens ...  StockNewsJournal
Sector Gamma As Buys Bristol-Myers Squibb Company, Perrigo Co PLC, Abbott ...
Sector Gamma As initiated holdings in Perrigo Co PLC. The purchase prices were between $66.39 and $87.23, with an estimated average price of $76.04.
Cancer Setback Leaves Bristol-Myers Vulnerable to Takeover
At a Chicago convention jammed with thousands of doctors in 2015, a buzz of excitement rippled through the hall as a researcher revealed data showing that a Bristol-Myers Squibb Co. drug cocktail had remarkable success in fighting a deadly form of skin ...
Bristol-Myers Squibb Company: Bristol-Myers Squibb Voluntarily Recalls One ...  The Wall Street Transcript
Eastern Bank Holding in Bristol Myers Squibb Co. (BMY) Has Boosted by $3.48 ...  WeeklyHub
Is the Market Wrong About Bristol-Myers Squibb?
Bristol-Myers Squibb (BMS) (NYSE:BMY) might be the pharmaceutical company equivalent of the late comedian Rodney Dangerfield.
Target Price ($57.18) for Bristol-Myers Squibb Company (BMY) now above Open ...  NY Stock News
Wills Financial Group Upped Nike (NKE) Position; Bristol Myers Squibb Co ...  BZ Weekly